Cargando…

αβ-Double Negative CD4/CD8 (CD56) T cell (DNTs) in metastatic melanoma: basal frequency and behaviour during Ipilimumab treatment. Preliminary evaluations

Detalles Bibliográficos
Autores principales: De Tullio, Giacoma, Strippoli, Sabino, Angarano, Rosa, De Fazio, Vincenza, Sgherza, Nicola, Negri, Antonio, Albano, Anna, Iacopino, Pasquale, Guarini, Attilio, Guida, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315263/
http://dx.doi.org/10.1186/1479-5876-13-S1-O10
_version_ 1782355447565516800
author De Tullio, Giacoma
Strippoli, Sabino
Angarano, Rosa
De Fazio, Vincenza
Sgherza, Nicola
Negri, Antonio
Albano, Anna
Iacopino, Pasquale
Guarini, Attilio
Guida, Michele
author_facet De Tullio, Giacoma
Strippoli, Sabino
Angarano, Rosa
De Fazio, Vincenza
Sgherza, Nicola
Negri, Antonio
Albano, Anna
Iacopino, Pasquale
Guarini, Attilio
Guida, Michele
author_sort De Tullio, Giacoma
collection PubMed
description
format Online
Article
Text
id pubmed-4315263
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43152632015-02-12 αβ-Double Negative CD4/CD8 (CD56) T cell (DNTs) in metastatic melanoma: basal frequency and behaviour during Ipilimumab treatment. Preliminary evaluations De Tullio, Giacoma Strippoli, Sabino Angarano, Rosa De Fazio, Vincenza Sgherza, Nicola Negri, Antonio Albano, Anna Iacopino, Pasquale Guarini, Attilio Guida, Michele J Transl Med Oral Presentation BioMed Central 2015-01-15 /pmc/articles/PMC4315263/ http://dx.doi.org/10.1186/1479-5876-13-S1-O10 Text en Copyright © 2015 De Tullio et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Oral Presentation
De Tullio, Giacoma
Strippoli, Sabino
Angarano, Rosa
De Fazio, Vincenza
Sgherza, Nicola
Negri, Antonio
Albano, Anna
Iacopino, Pasquale
Guarini, Attilio
Guida, Michele
αβ-Double Negative CD4/CD8 (CD56) T cell (DNTs) in metastatic melanoma: basal frequency and behaviour during Ipilimumab treatment. Preliminary evaluations
title αβ-Double Negative CD4/CD8 (CD56) T cell (DNTs) in metastatic melanoma: basal frequency and behaviour during Ipilimumab treatment. Preliminary evaluations
title_full αβ-Double Negative CD4/CD8 (CD56) T cell (DNTs) in metastatic melanoma: basal frequency and behaviour during Ipilimumab treatment. Preliminary evaluations
title_fullStr αβ-Double Negative CD4/CD8 (CD56) T cell (DNTs) in metastatic melanoma: basal frequency and behaviour during Ipilimumab treatment. Preliminary evaluations
title_full_unstemmed αβ-Double Negative CD4/CD8 (CD56) T cell (DNTs) in metastatic melanoma: basal frequency and behaviour during Ipilimumab treatment. Preliminary evaluations
title_short αβ-Double Negative CD4/CD8 (CD56) T cell (DNTs) in metastatic melanoma: basal frequency and behaviour during Ipilimumab treatment. Preliminary evaluations
title_sort αβ-double negative cd4/cd8 (cd56) t cell (dnts) in metastatic melanoma: basal frequency and behaviour during ipilimumab treatment. preliminary evaluations
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315263/
http://dx.doi.org/10.1186/1479-5876-13-S1-O10
work_keys_str_mv AT detulliogiacoma abdoublenegativecd4cd8cd56tcelldntsinmetastaticmelanomabasalfrequencyandbehaviourduringipilimumabtreatmentpreliminaryevaluations
AT strippolisabino abdoublenegativecd4cd8cd56tcelldntsinmetastaticmelanomabasalfrequencyandbehaviourduringipilimumabtreatmentpreliminaryevaluations
AT angaranorosa abdoublenegativecd4cd8cd56tcelldntsinmetastaticmelanomabasalfrequencyandbehaviourduringipilimumabtreatmentpreliminaryevaluations
AT defaziovincenza abdoublenegativecd4cd8cd56tcelldntsinmetastaticmelanomabasalfrequencyandbehaviourduringipilimumabtreatmentpreliminaryevaluations
AT sgherzanicola abdoublenegativecd4cd8cd56tcelldntsinmetastaticmelanomabasalfrequencyandbehaviourduringipilimumabtreatmentpreliminaryevaluations
AT negriantonio abdoublenegativecd4cd8cd56tcelldntsinmetastaticmelanomabasalfrequencyandbehaviourduringipilimumabtreatmentpreliminaryevaluations
AT albanoanna abdoublenegativecd4cd8cd56tcelldntsinmetastaticmelanomabasalfrequencyandbehaviourduringipilimumabtreatmentpreliminaryevaluations
AT iacopinopasquale abdoublenegativecd4cd8cd56tcelldntsinmetastaticmelanomabasalfrequencyandbehaviourduringipilimumabtreatmentpreliminaryevaluations
AT guariniattilio abdoublenegativecd4cd8cd56tcelldntsinmetastaticmelanomabasalfrequencyandbehaviourduringipilimumabtreatmentpreliminaryevaluations
AT guidamichele abdoublenegativecd4cd8cd56tcelldntsinmetastaticmelanomabasalfrequencyandbehaviourduringipilimumabtreatmentpreliminaryevaluations